Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Related to this article

AI oncology data, trispecifics, nitrosamine testing: what three new deals mean for CMC and QA teams.

October 23rd, 2026

Why BMS, Roche, and LGM Pharma Outsourced Key Capabilities

BMS-Tempus, Roche-Zymeworks, and LGM-Sannova deals show what AI data, trispecifics, and nitrosamine testing mean for CMC, QA, and development teams.

October 22nd, 2026

Ask the Expert: Choosing Ingredient Suppliers

Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.

Reshaping CMC Development Services

Articles in this issue

Related to this article

Trending on Pharmaceutical Technology

From URS to Acceptance Evidence: Defining and Testing Interfaces in Pen Injector Assembly

AAPS PharmSci 360 2026: IND-Enabling Studies vs Animal Data

PharmTech Weekly Roundup—October 23, 2026: CMC Considerations, Rare Disease Development, Standards Harmonization

Formulation Risk Needs One Accountable Owner: AAPS PharmSci 360 2026

AAPS PharmSci 360 2026: AI Tools, Regulations, and Preparedness